<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000535569"><TermName>ispinesib</TermName><TermPronunciation>(is-PIN-eh-sib)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. Ispinesib blocks a protein that tumor cells need to divide. It is a type of mitotic inhibitor. Also called SB-715992.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000704091" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ispinesib&quot;" language="en" id="_3"/><MediaLink ref="CDR0000704090" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ispinesib&quot;" language="es" id="_4"/><SpanishTermName>ispinesib</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. El ispinesib bloquea una proteína que el tumor necesita para multiplicarse. Es un tipo de inhibidor mitótico. También se llama SB-715992.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-02-16</DateFirstPublished><DateLastModified>2007-02-12</DateLastModified></GlossaryTerm>
